-
Get Involved
Ground SupportHouston-based nonprofit offers free rides to and from medical appointments for people with cancer.
by Thomas Celona
-
Policy Matters
Clinical Trial Endpoints for Timely Drug DevelopmentAs patients live longer with cancer, scientists need to rethink how to determine if a new drug is safe and effective.
by Kenneth Anderson, MD
-
Taking Answers Home
Advocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
-
Get Involved
Creating ConnectionsChemo Companions ensures people with cancer do not have to be alone during their chemotherapy treatments.
by Thomas Celona
-
Policy Matters
Cancer Research Funding Faces Uncertain FutureThe AACR is planning numerous initiatives in 2024 to bolster congressional support.
by Jon Retzlaff, MBA, MPA
-
Doctors Urge Need for ‘Common Sense Oncology’
A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
Policy Matters
Taking Action to Support Cancer ResearchThe AACR releases AACR Cancer Progress Report 2023, announces Cancer Centers Alliance, and joins 11th Rally for Medical Research.
by Benjamin Krinsky, PhD
-
Progress in Rare Cancers
With the rise of patient-driven research and registries, scientists are making advances in understanding, diagnosing and treating many of the least common cancer types.
by Kendall K. Morgan
-
Get Involved
A Helping HandThe Singletons take care of the shopping so single parents can focus on their cancer treatments.
by Thomas Celona
-
Patient Advocates as Research Partners
Speakers at SABCS discuss how people who have lived with breast cancer can be valuable partners in research.
by Eric Fitzsimmons
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore